Literature DB >> 17024657

Analysis of connexin expression during mouse Schwann cell development identifies connexin29 as a novel marker for the transition of neural crest to precursor cells.

Jing Li1, Hans-Werner Habbes, Jürgen Eiberger, Klaus Willecke, Rolf Dermietzel, Carola Meier.   

Abstract

Connexins are transmembrane proteins forming gap junction channels for direct intercellular and, for example in myelinating glia cells, intracellular communication. In mature myelin-forming Schwann cells, expression of multiple connexins, i.e. connexin (Cx) 43, Cx29, Cx32, and Cx46 (after nerve injury) has been detected. However, little is known about connexin protein expression during Schwann cell development. Here we use histochemical methods on wildtype and Cx29lacZ transgenic mice to investigate the developmental expression of connexins in the Schwann cell lineage. Our data demonstrate that in the mouse Cx43, Cx29, and Cx32 protein expression is activated in a developmental sequence that is clearly correlated with major developmental steps in the lineage. Only Cx43 was expressed from neural crest cells onwards. Cx29 protein expression was absent from neural crest cells but appeared as neural crest cells generated precursors (embryonic day 12) both in vivo and in vitro. This identifies Cx29 as a novel marker for cells of the defined Schwann cell lineage. The only exception to this were dorsal roots, where the expression of Cx29 was delayed four days relative to ventral roots and spinal nerves. Expression of Cx32 commenced postnatally, coinciding with the onset of myelination. Thus, the coordinated expression of connexin proteins in cells of the embryonic and postnatal Schwann cell lineage might point to a potential role in peripheral nerve development and maturation. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17024657     DOI: 10.1002/glia.20427

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  Connexin and pannexin mediated cell-cell communication.

Authors:  Eliana Scemes; Sylvia O Suadicani; Gerhard Dahl; David C Spray
Journal:  Neuron Glia Biol       Date:  2007-08

Review 2.  Gap junction communication in myelinating glia.

Authors:  Anna Nualart-Marti; Carles Solsona; R Douglas Fields
Journal:  Biochim Biophys Acta       Date:  2012-02-03

Review 3.  Metabolic Transporters in the Peripheral Nerve-What, Where, and Why?

Authors:  Atul Rawat; Brett M Morrison
Journal:  Neurotherapeutics       Date:  2021-11-12       Impact factor: 6.088

Review 4.  Revisiting the stimulus-secretion coupling in the adrenal medulla: role of gap junction-mediated intercellular communication.

Authors:  Claude Colomer; Michel G Desarménien; Nathalie C Guérineau
Journal:  Mol Neurobiol       Date:  2009-05-16       Impact factor: 5.590

5.  Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.

Authors:  Meejin Ahn; Jonathan Lee; Andreas Gustafsson; Alan Enriquez; Eric Lancaster; Jai-Yoon Sul; Philip G Haydon; David L Paul; Yan Huang; Charles K Abrams; Steven S Scherer
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

6.  Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein.

Authors:  Andrew Marsh; Katherine Casey-Green; Fay Probert; David Withall; Daniel A Mitchell; Suzanne J Dilly; Sean James; Wade Dimitri; Sweta R Ladwa; Paul C Taylor; Donald R J Singer
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 7.  Adult tissue-derived neural crest-like stem cells: Sources, regulatory networks, and translational potential.

Authors:  Pihu Mehrotra; Georgios Tseropoulos; Marianne E Bronner; Stelios T Andreadis
Journal:  Stem Cells Transl Med       Date:  2019-11-18       Impact factor: 6.940

8.  Co-culture of neural crest stem cells (NCSC) and insulin producing beta-TC6 cells results in cadherin junctions and protection against cytokine-induced beta-cell death.

Authors:  Anongnad Ngamjariyawat; Kyril Turpaev; Svitlana Vasylovska; Elena N Kozlova; Nils Welsh
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.